We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exploring Analyst Estimates for MetLife (MET) Q1 Earnings, Beyond Revenue and EPS
Read MoreHide Full Article
Analysts on Wall Street project that MetLife (MET - Free Report) will announce quarterly earnings of $2.23 per share in its forthcoming report, representing an increase of 13.8% year over year. Revenues are projected to reach $19.2 billion, increasing 2% from the same quarter last year.
The current level reflects a downward revision of 1.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some MetLife metrics that Wall Street analysts commonly model and monitor.
Based on the collective assessment of analysts, 'Revenue- Premiums' should arrive at $11.49 billion. The estimate points to a change of -2% from the year-ago quarter.
Analysts predict that the 'Revenue- Other Revenues' will reach $705.48 million. The estimate suggests a change of +2.7% year over year.
The average prediction of analysts places 'Revenue- Universal life and investment-type product policy fees' at $1.29 billion. The estimate points to a change of +5.2% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Net investment income' should come in at $5.68 billion. The estimate suggests a change of +16.3% year over year.
The combined assessment of analysts suggests that 'Total Adjusted Revenue- Latin America' will likely reach $2.17 billion. The estimate indicates a year-over-year change of +13.2%.
The consensus among analysts is that 'Adjusted Revenue- Corporate & other- Net investment income' will reach $1.08 billion. The estimate indicates a change of +1425.8% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Total Adjusted Revenue- EMEA' of $807.11 million. The estimate indicates a year-over-year change of +11.2%.
It is projected by analysts that the 'Total Adjusted Revenue- Asia' will reach $3.14 billion. The estimate points to a change of +8.9% from the year-ago quarter.
The consensus estimate for 'Adjusted Revenue- Asia- Net investment income' stands at $1.41 billion. The estimate points to a change of +16.8% from the year-ago quarter.
Analysts expect 'Adjusted Revenue- EMEA- Net investment income' to come in at $66.84 million. The estimate points to a change of +15.2% from the year-ago quarter.
Analysts forecast 'Adjusted Revenue- Latin America- Net investment income' to reach $456.73 million. The estimate points to a change of +12.2% from the year-ago quarter.
Analysts' assessment points toward 'Adjusted Revenue- Asia- Other Revenues' reaching $19.43 million. The estimate indicates a change of +29.5% from the prior-year quarter.
Shares of MetLife have demonstrated returns of +13.3% over the past month compared to the Zacks S&P 500 composite's +10.5% change. With a Zacks Rank #3 (Hold), MET is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Exploring Analyst Estimates for MetLife (MET) Q1 Earnings, Beyond Revenue and EPS
Analysts on Wall Street project that MetLife (MET - Free Report) will announce quarterly earnings of $2.23 per share in its forthcoming report, representing an increase of 13.8% year over year. Revenues are projected to reach $19.2 billion, increasing 2% from the same quarter last year.
The current level reflects a downward revision of 1.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some MetLife metrics that Wall Street analysts commonly model and monitor.
Based on the collective assessment of analysts, 'Revenue- Premiums' should arrive at $11.49 billion. The estimate points to a change of -2% from the year-ago quarter.
Analysts predict that the 'Revenue- Other Revenues' will reach $705.48 million. The estimate suggests a change of +2.7% year over year.
The average prediction of analysts places 'Revenue- Universal life and investment-type product policy fees' at $1.29 billion. The estimate points to a change of +5.2% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Net investment income' should come in at $5.68 billion. The estimate suggests a change of +16.3% year over year.
The combined assessment of analysts suggests that 'Total Adjusted Revenue- Latin America' will likely reach $2.17 billion. The estimate indicates a year-over-year change of +13.2%.
The consensus among analysts is that 'Adjusted Revenue- Corporate & other- Net investment income' will reach $1.08 billion. The estimate indicates a change of +1425.8% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Total Adjusted Revenue- EMEA' of $807.11 million. The estimate indicates a year-over-year change of +11.2%.
It is projected by analysts that the 'Total Adjusted Revenue- Asia' will reach $3.14 billion. The estimate points to a change of +8.9% from the year-ago quarter.
The consensus estimate for 'Adjusted Revenue- Asia- Net investment income' stands at $1.41 billion. The estimate points to a change of +16.8% from the year-ago quarter.
Analysts expect 'Adjusted Revenue- EMEA- Net investment income' to come in at $66.84 million. The estimate points to a change of +15.2% from the year-ago quarter.
Analysts forecast 'Adjusted Revenue- Latin America- Net investment income' to reach $456.73 million. The estimate points to a change of +12.2% from the year-ago quarter.
Analysts' assessment points toward 'Adjusted Revenue- Asia- Other Revenues' reaching $19.43 million. The estimate indicates a change of +29.5% from the prior-year quarter.
View all Key Company Metrics for MetLife here>>>Shares of MetLife have demonstrated returns of +13.3% over the past month compared to the Zacks S&P 500 composite's +10.5% change. With a Zacks Rank #3 (Hold), MET is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .